“Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis”, Reumatismo, vol. 69, no. 4, pp. 184–188, Dec. 2017, doi: 10.4081/reumatismo.2017.1013.